Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Small Molecules

Discovery & Development Drug Discovery

A Reawakening of Small Molecule Drug Development

| Marcelo Bigal

Emerging technologies are proving that small molecules aren't yesterday's news.

Manufacture Trends & Forecasts

Crafting a Magic Bullet

| Stephanie Sutton

How is the field of antibody drug conjugates being reshaped?

Business & Regulation Business Practice

Seriously Y'all Stop It

| Stephanie Sutton

Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.

Discovery & Development Drug Discovery

Staying on the Track to Eradication

| Rosanne Rotondo

A diverse range of malaria treatments will make all the difference in the prevention of resistance.

Manufacture Bioprocessing - Upstream & Downstream

The Rise of mRNA: New Era, New Challenges

| Amélie Boulais, Jay Zhang, Nitin Chopra

Manufacturers must look to ease the headaches associated with the manufacture of mRNA-based products.

Discovery & Development Clinical Trials

Malaysia in the Middle: Tackling Hep C in an Unfair World

| Angus Stewart

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

Manufacture Formulation

A Nice Cup of RDT

| Aditya Kumar

Has pharma fully acknowledged the power of rapid-dissolve tablet technologies?

Manufacture Small Molecules

(Precious) Metal Will Never Die

| Sponsored by Sabin Metal

Precious metals-bearing catalysts are essential in some pharma processes – but, once they’re spent, they still hold value.

Business & Regulation Small Molecules

The Lilly and the Kumquat

| Angus Stewart

Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.

Business & Regulation Analytical Science

AI Reunites Pharma with Mother Nature

| Stephanie Sutton, Angus Stewart

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register